Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Gilead Sciences agreed to pay $202 million to the U.S. government and various states to settle claims it used speaker ...

Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the company of paying ...

Shares of Gilead Sciences Inc. GILD shed 2.00% to $104.21 Tuesday, on what proved to be an all-around positive trading ...

Gilead Sciences Inc. reached a $202 settlement with the US to resolve claims that it paid doctors and gave them meals and ...

Over the years, a host of large drugmakers have inked settlements with the federal authorities to resolve allegations that ...

The company paid to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV medicines.

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Gilead Sciences offers steady dividend growth with a 2.99% yield. Read why the analyst nonetheless has a neutral rating on ...

The company's first-quarter revenue slipped 0.3% year-over-year to $6.67 billion, while analysts surveyed by Visible Alpha ...

The Handmaid's Tale' is inching towards its conclusion and June, Luke and Moira are putting their plans to take down Gilead ...